Usefulness of Transesophageal Echocardiography for Predicting Covert Paroxysmal Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source

Background: Covert paroxysmal atrial fibrillation (CPAF) is a major cause of embolic stroke of undetermined source (ESUS). However, detecting PAF during hospitalization in these patients is difficult. Objectives: This study aimed to determine whether findings of transesophageal echocardiography (TEE...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cerebrovascular Diseases Extra 2019-09, Vol.9 (3), p.98-106
Hauptverfasser: Ohya, Yuichiro, Osaki, Masato, Fujimoto, Shigeru, Jinnouchi, Juro, Matsuki, Takayuki, Mezuki, Satomi, Kumamoto, Masaya, Kanazawa, Makoto, Tagawa, Naoki, Ago, Tetsuro, Kitazono, Takanari, Arakawa, Shuji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 106
container_issue 3
container_start_page 98
container_title Cerebrovascular Diseases Extra
container_volume 9
creator Ohya, Yuichiro
Osaki, Masato
Fujimoto, Shigeru
Jinnouchi, Juro
Matsuki, Takayuki
Mezuki, Satomi
Kumamoto, Masaya
Kanazawa, Makoto
Tagawa, Naoki
Ago, Tetsuro
Kitazono, Takanari
Arakawa, Shuji
description Background: Covert paroxysmal atrial fibrillation (CPAF) is a major cause of embolic stroke of undetermined source (ESUS). However, detecting PAF during hospitalization in these patients is difficult. Objectives: This study aimed to determine whether findings of transesophageal echocardiography (TEE) during hospitalization are associated with later detection of PAF in patients with ESUS. Method: We retrospectively studied 348 patients with ESUS who were admitted to our hospital within 1 week of onset. These patients met the criteria of ESUS, underwent TEE during hospitalization, and were followed up for at least 1 year. Results: We found PAF in 35 (10.0%) patients. In patients with PAF, spontaneous echo contrast (SEC) and low left atrial appendage flow (LAAF) by TEE and enlargement of the left atrial dimension (LAD) by transthoracic echocardiography were identified more frequently compared with those who did not have PAF. In multivariate analysis, SEC and an LAD ≥42 mm were independently associated with later detection of PAF (p < 0.05). An association of LAAF
doi_str_mv 10.1159/000502713
format Article
fullrecord <record><control><sourceid>gale_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1159_000502713</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A630892024</galeid><doaj_id>oai_doaj_org_article_f5ce17198f8f486bb7335e57f0848dde</doaj_id><sourcerecordid>A630892024</sourcerecordid><originalsourceid>FETCH-LOGICAL-c585t-3280d8a37b6d3c7561570e13a9f1e21b6229db6115ff5515bc651051c2eef9883</originalsourceid><addsrcrecordid>eNptkk1vEzEQhlcIRKvSA3eEVuIChxR7vf7YC1IUpVCpEpXanC2vPd443bWDvSnkr_BrcUgILUI-2Bo_887MqymK1xhdYEybjwghiiqOybPiFDNWT2hN2fNH75PiPKVVxhBDmDT4ZXFCMK0rLtBp8XORwG56DymVwZZ3UfkEKayXqgPVl3O9DFpF40IX1Xq5LW2I5U0E4_TofFfOwgPEsbxRMfzYpiFnTMfo8nXp2uj6Xo0u-NL5TIwO_JjK725clvOhDb3T5e0Ywz3sCi-8gRHi4DyY8jZsooZXxQur-gTnh_usWFzO72ZfJtdfP1_NptcTTQUdJ6QSyAhFeMsM0ZwyTDkCTFRjMVS4ZVXVmJZlr6ylFNNWM4oRxboCsI0Q5Ky42uuaoFZyHd2g4lYG5eTvQIidVHF0ugdpqQbMcSOssLVgbcsJoUC5RaIWxkDW-rTXWm_aAYzOI0fVPxF9-uPdUnbhQTIueI1ZFnh_EIjh2wbSKAeXNGQnPYRNknkYhgnHbNf3u3_QVfbNZ6tkRRBuMKl5lamLPdWpPIDzNuS6Oh8Dg9PBg3U5PmUEiaZCVZ0TPuwTdAwpRbDH7jGSu42Tx43L7NvH4x7JP_v1t8d7FTuIR2A2n-8l5NrYTL35L3Wo8guZuOcd</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2301913472</pqid></control><display><type>article</type><title>Usefulness of Transesophageal Echocardiography for Predicting Covert Paroxysmal Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Karger Open Access</source><creator>Ohya, Yuichiro ; Osaki, Masato ; Fujimoto, Shigeru ; Jinnouchi, Juro ; Matsuki, Takayuki ; Mezuki, Satomi ; Kumamoto, Masaya ; Kanazawa, Makoto ; Tagawa, Naoki ; Ago, Tetsuro ; Kitazono, Takanari ; Arakawa, Shuji</creator><creatorcontrib>Ohya, Yuichiro ; Osaki, Masato ; Fujimoto, Shigeru ; Jinnouchi, Juro ; Matsuki, Takayuki ; Mezuki, Satomi ; Kumamoto, Masaya ; Kanazawa, Makoto ; Tagawa, Naoki ; Ago, Tetsuro ; Kitazono, Takanari ; Arakawa, Shuji</creatorcontrib><description>Background: Covert paroxysmal atrial fibrillation (CPAF) is a major cause of embolic stroke of undetermined source (ESUS). However, detecting PAF during hospitalization in these patients is difficult. Objectives: This study aimed to determine whether findings of transesophageal echocardiography (TEE) during hospitalization are associated with later detection of PAF in patients with ESUS. Method: We retrospectively studied 348 patients with ESUS who were admitted to our hospital within 1 week of onset. These patients met the criteria of ESUS, underwent TEE during hospitalization, and were followed up for at least 1 year. Results: We found PAF in 35 (10.0%) patients. In patients with PAF, spontaneous echo contrast (SEC) and low left atrial appendage flow (LAAF) by TEE and enlargement of the left atrial dimension (LAD) by transthoracic echocardiography were identified more frequently compared with those who did not have PAF. In multivariate analysis, SEC and an LAD ≥42 mm were independently associated with later detection of PAF (p &lt; 0.05). An association of LAAF &lt;46.9 cm/s and PAF was marginal (p = 0.09). The specificity of the combined finding of SEC and/or LAAF with that of LAD increased up to 90%, while that of LAD alone was 70%. Conclusions: The findings of TEE during hospitalization may be useful for identifying patients at increased risk of CPAF in patients with ESUS.</description><identifier>ISSN: 1664-5456</identifier><identifier>EISSN: 1664-5456</identifier><identifier>DOI: 10.1159/000502713</identifier><identifier>PMID: 31542780</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Aged ; Aged, 80 and over ; Aneurysms ; Anticoagulants ; Atrial Appendage - diagnostic imaging ; Atrial fibrillation ; Atrial Fibrillation - complications ; Atrial Fibrillation - diagnostic imaging ; Blood clots ; Blood pressure ; Cardiac arrhythmia ; Cardiology ; Cardiovascular disease ; Care and treatment ; Echocardiography ; Echocardiography, Transesophageal ; Embolic stroke of undetermined source ; Embolisms ; Female ; Fistula ; Heart ; Hospitalization ; Humans ; Intracranial Embolism - diagnostic imaging ; Intracranial Embolism - etiology ; Male ; Middle Aged ; Original Paper ; Pathogenesis ; Predictive Value of Tests ; Prognosis ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Stroke ; Stroke - diagnostic imaging ; Stroke - etiology ; Time Factors ; Transesophageal echocardiography</subject><ispartof>Cerebrovascular Diseases Extra, 2019-09, Vol.9 (3), p.98-106</ispartof><rights>2019 The Author(s) Published by S. Karger AG, Basel</rights><rights>2019 The Author(s) Published by S. Karger AG, Basel.</rights><rights>COPYRIGHT 2019 S. Karger AG</rights><rights>Copyright © 2019 by S. Karger AG, Basel 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c585t-3280d8a37b6d3c7561570e13a9f1e21b6229db6115ff5515bc651051c2eef9883</citedby><cites>FETCH-LOGICAL-c585t-3280d8a37b6d3c7561570e13a9f1e21b6229db6115ff5515bc651051c2eef9883</cites><orcidid>0000-0003-4560-6594</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787416/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787416/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,27612,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31542780$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohya, Yuichiro</creatorcontrib><creatorcontrib>Osaki, Masato</creatorcontrib><creatorcontrib>Fujimoto, Shigeru</creatorcontrib><creatorcontrib>Jinnouchi, Juro</creatorcontrib><creatorcontrib>Matsuki, Takayuki</creatorcontrib><creatorcontrib>Mezuki, Satomi</creatorcontrib><creatorcontrib>Kumamoto, Masaya</creatorcontrib><creatorcontrib>Kanazawa, Makoto</creatorcontrib><creatorcontrib>Tagawa, Naoki</creatorcontrib><creatorcontrib>Ago, Tetsuro</creatorcontrib><creatorcontrib>Kitazono, Takanari</creatorcontrib><creatorcontrib>Arakawa, Shuji</creatorcontrib><title>Usefulness of Transesophageal Echocardiography for Predicting Covert Paroxysmal Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source</title><title>Cerebrovascular Diseases Extra</title><addtitle>Cerebrovasc Dis Extra</addtitle><description>Background: Covert paroxysmal atrial fibrillation (CPAF) is a major cause of embolic stroke of undetermined source (ESUS). However, detecting PAF during hospitalization in these patients is difficult. Objectives: This study aimed to determine whether findings of transesophageal echocardiography (TEE) during hospitalization are associated with later detection of PAF in patients with ESUS. Method: We retrospectively studied 348 patients with ESUS who were admitted to our hospital within 1 week of onset. These patients met the criteria of ESUS, underwent TEE during hospitalization, and were followed up for at least 1 year. Results: We found PAF in 35 (10.0%) patients. In patients with PAF, spontaneous echo contrast (SEC) and low left atrial appendage flow (LAAF) by TEE and enlargement of the left atrial dimension (LAD) by transthoracic echocardiography were identified more frequently compared with those who did not have PAF. In multivariate analysis, SEC and an LAD ≥42 mm were independently associated with later detection of PAF (p &lt; 0.05). An association of LAAF &lt;46.9 cm/s and PAF was marginal (p = 0.09). The specificity of the combined finding of SEC and/or LAAF with that of LAD increased up to 90%, while that of LAD alone was 70%. Conclusions: The findings of TEE during hospitalization may be useful for identifying patients at increased risk of CPAF in patients with ESUS.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aneurysms</subject><subject>Anticoagulants</subject><subject>Atrial Appendage - diagnostic imaging</subject><subject>Atrial fibrillation</subject><subject>Atrial Fibrillation - complications</subject><subject>Atrial Fibrillation - diagnostic imaging</subject><subject>Blood clots</subject><subject>Blood pressure</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology</subject><subject>Cardiovascular disease</subject><subject>Care and treatment</subject><subject>Echocardiography</subject><subject>Echocardiography, Transesophageal</subject><subject>Embolic stroke of undetermined source</subject><subject>Embolisms</subject><subject>Female</subject><subject>Fistula</subject><subject>Heart</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Intracranial Embolism - diagnostic imaging</subject><subject>Intracranial Embolism - etiology</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Original Paper</subject><subject>Pathogenesis</subject><subject>Predictive Value of Tests</subject><subject>Prognosis</subject><subject>Retrospective Studies</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Stroke</subject><subject>Stroke - diagnostic imaging</subject><subject>Stroke - etiology</subject><subject>Time Factors</subject><subject>Transesophageal echocardiography</subject><issn>1664-5456</issn><issn>1664-5456</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>M--</sourceid><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNptkk1vEzEQhlcIRKvSA3eEVuIChxR7vf7YC1IUpVCpEpXanC2vPd443bWDvSnkr_BrcUgILUI-2Bo_887MqymK1xhdYEybjwghiiqOybPiFDNWT2hN2fNH75PiPKVVxhBDmDT4ZXFCMK0rLtBp8XORwG56DymVwZZ3UfkEKayXqgPVl3O9DFpF40IX1Xq5LW2I5U0E4_TofFfOwgPEsbxRMfzYpiFnTMfo8nXp2uj6Xo0u-NL5TIwO_JjK725clvOhDb3T5e0Ywz3sCi-8gRHi4DyY8jZsooZXxQur-gTnh_usWFzO72ZfJtdfP1_NptcTTQUdJ6QSyAhFeMsM0ZwyTDkCTFRjMVS4ZVXVmJZlr6ylFNNWM4oRxboCsI0Q5Ky42uuaoFZyHd2g4lYG5eTvQIidVHF0ugdpqQbMcSOssLVgbcsJoUC5RaIWxkDW-rTXWm_aAYzOI0fVPxF9-uPdUnbhQTIueI1ZFnh_EIjh2wbSKAeXNGQnPYRNknkYhgnHbNf3u3_QVfbNZ6tkRRBuMKl5lamLPdWpPIDzNuS6Oh8Dg9PBg3U5PmUEiaZCVZ0TPuwTdAwpRbDH7jGSu42Tx43L7NvH4x7JP_v1t8d7FTuIR2A2n-8l5NrYTL35L3Wo8guZuOcd</recordid><startdate>20190901</startdate><enddate>20190901</enddate><creator>Ohya, Yuichiro</creator><creator>Osaki, Masato</creator><creator>Fujimoto, Shigeru</creator><creator>Jinnouchi, Juro</creator><creator>Matsuki, Takayuki</creator><creator>Mezuki, Satomi</creator><creator>Kumamoto, Masaya</creator><creator>Kanazawa, Makoto</creator><creator>Tagawa, Naoki</creator><creator>Ago, Tetsuro</creator><creator>Kitazono, Takanari</creator><creator>Arakawa, Shuji</creator><general>S. Karger AG</general><general>Karger Publishers</general><scope>M--</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-4560-6594</orcidid></search><sort><creationdate>20190901</creationdate><title>Usefulness of Transesophageal Echocardiography for Predicting Covert Paroxysmal Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source</title><author>Ohya, Yuichiro ; Osaki, Masato ; Fujimoto, Shigeru ; Jinnouchi, Juro ; Matsuki, Takayuki ; Mezuki, Satomi ; Kumamoto, Masaya ; Kanazawa, Makoto ; Tagawa, Naoki ; Ago, Tetsuro ; Kitazono, Takanari ; Arakawa, Shuji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c585t-3280d8a37b6d3c7561570e13a9f1e21b6229db6115ff5515bc651051c2eef9883</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aneurysms</topic><topic>Anticoagulants</topic><topic>Atrial Appendage - diagnostic imaging</topic><topic>Atrial fibrillation</topic><topic>Atrial Fibrillation - complications</topic><topic>Atrial Fibrillation - diagnostic imaging</topic><topic>Blood clots</topic><topic>Blood pressure</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology</topic><topic>Cardiovascular disease</topic><topic>Care and treatment</topic><topic>Echocardiography</topic><topic>Echocardiography, Transesophageal</topic><topic>Embolic stroke of undetermined source</topic><topic>Embolisms</topic><topic>Female</topic><topic>Fistula</topic><topic>Heart</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Intracranial Embolism - diagnostic imaging</topic><topic>Intracranial Embolism - etiology</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Original Paper</topic><topic>Pathogenesis</topic><topic>Predictive Value of Tests</topic><topic>Prognosis</topic><topic>Retrospective Studies</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Stroke</topic><topic>Stroke - diagnostic imaging</topic><topic>Stroke - etiology</topic><topic>Time Factors</topic><topic>Transesophageal echocardiography</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohya, Yuichiro</creatorcontrib><creatorcontrib>Osaki, Masato</creatorcontrib><creatorcontrib>Fujimoto, Shigeru</creatorcontrib><creatorcontrib>Jinnouchi, Juro</creatorcontrib><creatorcontrib>Matsuki, Takayuki</creatorcontrib><creatorcontrib>Mezuki, Satomi</creatorcontrib><creatorcontrib>Kumamoto, Masaya</creatorcontrib><creatorcontrib>Kanazawa, Makoto</creatorcontrib><creatorcontrib>Tagawa, Naoki</creatorcontrib><creatorcontrib>Ago, Tetsuro</creatorcontrib><creatorcontrib>Kitazono, Takanari</creatorcontrib><creatorcontrib>Arakawa, Shuji</creatorcontrib><collection>Karger Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Cerebrovascular Diseases Extra</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohya, Yuichiro</au><au>Osaki, Masato</au><au>Fujimoto, Shigeru</au><au>Jinnouchi, Juro</au><au>Matsuki, Takayuki</au><au>Mezuki, Satomi</au><au>Kumamoto, Masaya</au><au>Kanazawa, Makoto</au><au>Tagawa, Naoki</au><au>Ago, Tetsuro</au><au>Kitazono, Takanari</au><au>Arakawa, Shuji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Usefulness of Transesophageal Echocardiography for Predicting Covert Paroxysmal Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source</atitle><jtitle>Cerebrovascular Diseases Extra</jtitle><addtitle>Cerebrovasc Dis Extra</addtitle><date>2019-09-01</date><risdate>2019</risdate><volume>9</volume><issue>3</issue><spage>98</spage><epage>106</epage><pages>98-106</pages><issn>1664-5456</issn><eissn>1664-5456</eissn><abstract>Background: Covert paroxysmal atrial fibrillation (CPAF) is a major cause of embolic stroke of undetermined source (ESUS). However, detecting PAF during hospitalization in these patients is difficult. Objectives: This study aimed to determine whether findings of transesophageal echocardiography (TEE) during hospitalization are associated with later detection of PAF in patients with ESUS. Method: We retrospectively studied 348 patients with ESUS who were admitted to our hospital within 1 week of onset. These patients met the criteria of ESUS, underwent TEE during hospitalization, and were followed up for at least 1 year. Results: We found PAF in 35 (10.0%) patients. In patients with PAF, spontaneous echo contrast (SEC) and low left atrial appendage flow (LAAF) by TEE and enlargement of the left atrial dimension (LAD) by transthoracic echocardiography were identified more frequently compared with those who did not have PAF. In multivariate analysis, SEC and an LAD ≥42 mm were independently associated with later detection of PAF (p &lt; 0.05). An association of LAAF &lt;46.9 cm/s and PAF was marginal (p = 0.09). The specificity of the combined finding of SEC and/or LAAF with that of LAD increased up to 90%, while that of LAD alone was 70%. Conclusions: The findings of TEE during hospitalization may be useful for identifying patients at increased risk of CPAF in patients with ESUS.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>31542780</pmid><doi>10.1159/000502713</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0003-4560-6594</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-5456
ispartof Cerebrovascular Diseases Extra, 2019-09, Vol.9 (3), p.98-106
issn 1664-5456
1664-5456
language eng
recordid cdi_crossref_primary_10_1159_000502713
source MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Karger Open Access
subjects Aged
Aged, 80 and over
Aneurysms
Anticoagulants
Atrial Appendage - diagnostic imaging
Atrial fibrillation
Atrial Fibrillation - complications
Atrial Fibrillation - diagnostic imaging
Blood clots
Blood pressure
Cardiac arrhythmia
Cardiology
Cardiovascular disease
Care and treatment
Echocardiography
Echocardiography, Transesophageal
Embolic stroke of undetermined source
Embolisms
Female
Fistula
Heart
Hospitalization
Humans
Intracranial Embolism - diagnostic imaging
Intracranial Embolism - etiology
Male
Middle Aged
Original Paper
Pathogenesis
Predictive Value of Tests
Prognosis
Retrospective Studies
Risk Assessment
Risk Factors
Stroke
Stroke - diagnostic imaging
Stroke - etiology
Time Factors
Transesophageal echocardiography
title Usefulness of Transesophageal Echocardiography for Predicting Covert Paroxysmal Atrial Fibrillation in Patients with Embolic Stroke of Undetermined Source
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T13%3A24%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Usefulness%20of%20Transesophageal%20Echocardiography%20for%20Predicting%20Covert%20Paroxysmal%20Atrial%20Fibrillation%20in%20Patients%20with%20Embolic%20Stroke%20of%20Undetermined%20Source&rft.jtitle=Cerebrovascular%20Diseases%20Extra&rft.au=Ohya,%20Yuichiro&rft.date=2019-09-01&rft.volume=9&rft.issue=3&rft.spage=98&rft.epage=106&rft.pages=98-106&rft.issn=1664-5456&rft.eissn=1664-5456&rft_id=info:doi/10.1159/000502713&rft_dat=%3Cgale_cross%3EA630892024%3C/gale_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2301913472&rft_id=info:pmid/31542780&rft_galeid=A630892024&rft_doaj_id=oai_doaj_org_article_f5ce17198f8f486bb7335e57f0848dde&rfr_iscdi=true